TrinityPoint Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
TrinityPoint Wealth's AMGN Position: Q4 2024 in Review
TrinityPoint Wealth increased its Amgen (AMGN) stake by 5.7% in Q4 2024, buying an estimated $142K and bringing the position to 8,846 shares worth $2.31M. The position accounts for 0.32% of the portfolio, ranked #74.
TrinityPoint Wealth first reported a position in AMGN in Q4 2018 and has held it in 24 quarters since. The position peaked at $2.7M in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- TrinityPoint Wealth held 8,846 shares of Amgen worth $2.31M as of Q4 2024.
- TrinityPoint Wealth bought 477 Amgen shares in Q4 2024, an estimated $142K.
- Amgen made up 0.32% of TrinityPoint Wealth's portfolio in Q4 2024, its #74 holding.
- TrinityPoint Wealth first reported a position in Amgen in Q4 2018 and has held it in 24 quarters since.
- TrinityPoint Wealth's Amgen position peaked at $2.7M in Q3 2024.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on TrinityPoint Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.